Migration, Proliferation, and Differentiation of Cord Blood Mesenchymal Stromal Cells Treated with Histone Deacetylase Inhibitor Valproic Acid
Mesenchymal stromal cells (MSC) have great potential for cellular therapies as they can be directed to differentiate into certain lineages or to exert paracrine effects at sites of injury. The interactions between stromal cell-derived factor (SDF)-1 and its receptors CXCR4 and CXCR7 play pivotal rol...
Saved in:
Main Authors: | Leah A. Marquez-Curtis, Yuanyuan Qiu, April Xu, Anna Janowska-Wieczorek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2014/610495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acetylation and Histone Deacetylase Inhibitors in Cancer
by: Madeleine S. Q. Kortenhorst, et al.
Published: (2006-01-01) -
Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
by: Androniki Kretsovali, et al.
Published: (2012-01-01) -
Histone Deacetylase Inhibitors: Synthesis of Tetrapeptide Analogue SAHA/TPX
by: Lynda Ekou, et al.
Published: (2011-01-01) -
Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives
by: Hua Zhang, et al.
Published: (2015-01-01) -
Comparison of Different Histone Deacetylase Inhibitors in Attenuating Inflammatory Pain in Rats
by: Yu Mao, et al.
Published: (2019-01-01)